Home » Topics » Conferences

Conferences
RSS

Oral valganciclovir is as effective as i.v. ganciclovir, with fewer complications

Feb. 4, 2000

News from ICMASKO 5: Pliva describes new azalides

Feb. 4, 2000

Novel foscarnet prodrugs show significantly enhanced activity against drug-resistant HIV

Feb. 4, 2000

Telithromycin featured in multiple presentations at ICMASKO 5

Feb. 4, 2000

Pliva presents new azithromycin derivatives at ICMASKO 5

Feb. 3, 2000

Preliminary results in volunteers reinforce the promise of DuPont's second-generation NNRTIs

Feb. 3, 2000

Emtricitabine-containing HAART regimen is highly efficacious in French study

Feb. 3, 2000

Edex/Viridal preferred, more efficacious than other ED therapies

Feb. 2, 2000

Patients prefer Invicorp over Caverject

Feb. 1, 2000

Bayer presents new candidate treatment for ED at ESIR

Jan. 31, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...